nodes	percent_of_prediction	percent_of_DWPC	metapath
Atenolol—ADRB1—Bromocriptine—type 2 diabetes mellitus	0.185	0.312	CbGbCtD
Atenolol—ABCB1—Linagliptin—type 2 diabetes mellitus	0.113	0.191	CbGbCtD
Atenolol—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.1	0.17	CbGbCtD
Atenolol—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0726	0.123	CbGbCtD
Atenolol—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0499	0.0844	CbGbCtD
Atenolol—ABCB1—Glyburide—type 2 diabetes mellitus	0.0372	0.0629	CbGbCtD
Atenolol—ABCB1—Losartan—type 2 diabetes mellitus	0.034	0.0575	CbGbCtD
Atenolol—Ibuprofen—THBD—type 2 diabetes mellitus	0.00138	0.179	CrCbGaD
Atenolol—Alprenolol—ADRB3—type 2 diabetes mellitus	0.00117	0.152	CrCbGaD
Atenolol—Pindolol—ADRB3—type 2 diabetes mellitus	0.00101	0.13	CrCbGaD
Atenolol—Ibuprofen—PLAT—type 2 diabetes mellitus	0.000946	0.122	CrCbGaD
Atenolol—Propranolol—ADRB3—type 2 diabetes mellitus	0.00055	0.0711	CrCbGaD
Atenolol—Ibuprofen—BCL2—type 2 diabetes mellitus	0.000544	0.0703	CrCbGaD
Atenolol—Betaxolol—CYP1A2—type 2 diabetes mellitus	0.000443	0.0574	CrCbGaD
Atenolol—Ibuprofen—PPARG—type 2 diabetes mellitus	0.000301	0.039	CrCbGaD
Atenolol—Chlorphenesin—CYP3A4—type 2 diabetes mellitus	0.000291	0.0376	CrCbGaD
Atenolol—Chlorphenesin—PTGS2—type 2 diabetes mellitus	0.000285	0.0368	CrCbGaD
Atenolol—Bisoprolol—CYP3A4—type 2 diabetes mellitus	0.000284	0.0367	CrCbGaD
Atenolol—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000268	0.000871	CcSEcCtD
Atenolol—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000268	0.000871	CcSEcCtD
Atenolol—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000267	0.000869	CcSEcCtD
Atenolol—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000266	0.000864	CcSEcCtD
Atenolol—Malaise—Metformin—type 2 diabetes mellitus	0.000265	0.000862	CcSEcCtD
Atenolol—Alopecia—Losartan—type 2 diabetes mellitus	0.000265	0.000862	CcSEcCtD
Atenolol—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000265	0.000862	CcSEcCtD
Atenolol—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000264	0.000859	CcSEcCtD
Atenolol—Syncope—Metformin—type 2 diabetes mellitus	0.000264	0.000857	CcSEcCtD
Atenolol—Oedema—Valsartan—type 2 diabetes mellitus	0.000263	0.000857	CcSEcCtD
Atenolol—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000263	0.000856	CcSEcCtD
Atenolol—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000263	0.000855	CcSEcCtD
Atenolol—Rash—Glipizide—type 2 diabetes mellitus	0.000262	0.000851	CcSEcCtD
Atenolol—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000261	0.00085	CcSEcCtD
Atenolol—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000261	0.00085	CcSEcCtD
Atenolol—Oedema—Orlistat—type 2 diabetes mellitus	0.00026	0.000847	CcSEcCtD
Atenolol—Headache—Glipizide—type 2 diabetes mellitus	0.00026	0.000845	CcSEcCtD
Atenolol—Palpitations—Metformin—type 2 diabetes mellitus	0.00026	0.000845	CcSEcCtD
Atenolol—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000259	0.000844	CcSEcCtD
Atenolol—Shock—Valsartan—type 2 diabetes mellitus	0.000259	0.000843	CcSEcCtD
Atenolol—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000258	0.00084	CcSEcCtD
Atenolol—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000258	0.000839	CcSEcCtD
Atenolol—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000257	0.000837	CcSEcCtD
Atenolol—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000257	0.000837	CcSEcCtD
Atenolol—Tension—Losartan—type 2 diabetes mellitus	0.000256	0.000833	CcSEcCtD
Atenolol—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000256	0.000833	CcSEcCtD
Atenolol—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000256	0.000831	CcSEcCtD
Atenolol—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000255	0.00083	CcSEcCtD
Atenolol—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000255	0.000829	CcSEcCtD
Atenolol—Nervousness—Losartan—type 2 diabetes mellitus	0.000254	0.000825	CcSEcCtD
Atenolol—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000252	0.000821	CcSEcCtD
Atenolol—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000252	0.000819	CcSEcCtD
Atenolol—Anorexia—Valsartan—type 2 diabetes mellitus	0.000251	0.000817	CcSEcCtD
Atenolol—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000251	0.000815	CcSEcCtD
Atenolol—Chest pain—Metformin—type 2 diabetes mellitus	0.00025	0.000814	CcSEcCtD
Atenolol—Malaise—Irbesartan—type 2 diabetes mellitus	0.00025	0.000814	CcSEcCtD
Atenolol—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000249	0.000811	CcSEcCtD
Atenolol—Headache—Pioglitazone—type 2 diabetes mellitus	0.000249	0.00081	CcSEcCtD
Atenolol—Syncope—Irbesartan—type 2 diabetes mellitus	0.000249	0.000809	CcSEcCtD
Atenolol—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000248	0.000806	CcSEcCtD
Atenolol—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000248	0.000805	CcSEcCtD
Atenolol—Discomfort—Metformin—type 2 diabetes mellitus	0.000247	0.000804	CcSEcCtD
Atenolol—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000247	0.000804	CcSEcCtD
Atenolol—Nausea—Glipizide—type 2 diabetes mellitus	0.000246	0.000802	CcSEcCtD
Atenolol—Hypotension—Valsartan—type 2 diabetes mellitus	0.000246	0.000801	CcSEcCtD
Atenolol—Vision blurred—Losartan—type 2 diabetes mellitus	0.000246	0.0008	CcSEcCtD
Atenolol—Constipation—Gliclazide—type 2 diabetes mellitus	0.000245	0.000798	CcSEcCtD
Atenolol—Pain—Gliclazide—type 2 diabetes mellitus	0.000245	0.000798	CcSEcCtD
Atenolol—Rash—Glimepiride—type 2 diabetes mellitus	0.000244	0.000794	CcSEcCtD
Atenolol—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000244	0.000793	CcSEcCtD
Atenolol—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000244	0.000793	CcSEcCtD
Atenolol—Rash—Sitagliptin—type 2 diabetes mellitus	0.000243	0.000792	CcSEcCtD
Atenolol—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000243	0.000791	CcSEcCtD
Atenolol—Headache—Glimepiride—type 2 diabetes mellitus	0.000243	0.000789	CcSEcCtD
Atenolol—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000242	0.000788	CcSEcCtD
Atenolol—Cough—Irbesartan—type 2 diabetes mellitus	0.000242	0.000787	CcSEcCtD
Atenolol—Headache—Sitagliptin—type 2 diabetes mellitus	0.000242	0.000786	CcSEcCtD
Atenolol—Oedema—Metformin—type 2 diabetes mellitus	0.00024	0.00078	CcSEcCtD
Atenolol—Tinnitus—Ramipril—type 2 diabetes mellitus	0.00024	0.00078	CcSEcCtD
Atenolol—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000239	0.000777	CcSEcCtD
Atenolol—Flushing—Ramipril—type 2 diabetes mellitus	0.000239	0.000776	CcSEcCtD
Atenolol—Insomnia—Valsartan—type 2 diabetes mellitus	0.000238	0.000775	CcSEcCtD
Atenolol—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000237	0.000769	CcSEcCtD
Atenolol—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000236	0.000769	CcSEcCtD
Atenolol—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000236	0.000768	CcSEcCtD
Atenolol—Shock—Metformin—type 2 diabetes mellitus	0.000236	0.000768	CcSEcCtD
Atenolol—Insomnia—Orlistat—type 2 diabetes mellitus	0.000235	0.000766	CcSEcCtD
Atenolol—Malaise—Losartan—type 2 diabetes mellitus	0.000235	0.000766	CcSEcCtD
Atenolol—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000235	0.000765	CcSEcCtD
Atenolol—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000235	0.000764	CcSEcCtD
Atenolol—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000235	0.000764	CcSEcCtD
Atenolol—Vertigo—Losartan—type 2 diabetes mellitus	0.000235	0.000763	CcSEcCtD
Atenolol—Somnolence—Valsartan—type 2 diabetes mellitus	0.000234	0.000762	CcSEcCtD
Atenolol—Syncope—Losartan—type 2 diabetes mellitus	0.000234	0.000761	CcSEcCtD
Atenolol—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000234	0.00076	CcSEcCtD
Atenolol—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000233	0.000759	CcSEcCtD
Atenolol—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000232	0.000754	CcSEcCtD
Atenolol—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000232	0.000754	CcSEcCtD
Atenolol—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000231	0.000751	CcSEcCtD
Atenolol—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000231	0.000751	CcSEcCtD
Atenolol—Palpitations—Losartan—type 2 diabetes mellitus	0.000231	0.00075	CcSEcCtD
Atenolol—Nausea—Glimepiride—type 2 diabetes mellitus	0.00023	0.000748	CcSEcCtD
Atenolol—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.00023	0.000747	CcSEcCtD
Atenolol—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000229	0.000746	CcSEcCtD
Atenolol—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000229	0.000746	CcSEcCtD
Atenolol—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000229	0.000745	CcSEcCtD
Atenolol—Asthenia—Glyburide—type 2 diabetes mellitus	0.000229	0.000745	CcSEcCtD
Atenolol—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000229	0.000745	CcSEcCtD
Atenolol—Anorexia—Metformin—type 2 diabetes mellitus	0.000229	0.000744	CcSEcCtD
Atenolol—Cough—Losartan—type 2 diabetes mellitus	0.000228	0.000741	CcSEcCtD
Atenolol—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000227	0.00074	CcSEcCtD
Atenolol—Alopecia—Ramipril—type 2 diabetes mellitus	0.000227	0.000739	CcSEcCtD
Atenolol—Fatigue—Valsartan—type 2 diabetes mellitus	0.000227	0.000739	CcSEcCtD
Atenolol—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000227	0.000737	CcSEcCtD
Atenolol—Oedema—Irbesartan—type 2 diabetes mellitus	0.000226	0.000736	CcSEcCtD
Atenolol—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000226	0.000736	CcSEcCtD
Atenolol—Pruritus—Glyburide—type 2 diabetes mellitus	0.000226	0.000735	CcSEcCtD
Atenolol—Constipation—Valsartan—type 2 diabetes mellitus	0.000225	0.000733	CcSEcCtD
Atenolol—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000225	0.000731	CcSEcCtD
Atenolol—Fatigue—Orlistat—type 2 diabetes mellitus	0.000224	0.00073	CcSEcCtD
Atenolol—Hypotension—Metformin—type 2 diabetes mellitus	0.000224	0.000729	CcSEcCtD
Atenolol—Shock—Irbesartan—type 2 diabetes mellitus	0.000223	0.000724	CcSEcCtD
Atenolol—Pain—Orlistat—type 2 diabetes mellitus	0.000223	0.000724	CcSEcCtD
Atenolol—Chest pain—Losartan—type 2 diabetes mellitus	0.000222	0.000723	CcSEcCtD
Atenolol—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000222	0.000721	CcSEcCtD
Atenolol—Anxiety—Losartan—type 2 diabetes mellitus	0.000221	0.00072	CcSEcCtD
Atenolol—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000221	0.000719	CcSEcCtD
Atenolol—Rash—Bromocriptine—type 2 diabetes mellitus	0.00022	0.000716	CcSEcCtD
Atenolol—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00022	0.000716	CcSEcCtD
Atenolol—Tension—Ramipril—type 2 diabetes mellitus	0.00022	0.000714	CcSEcCtD
Atenolol—Discomfort—Losartan—type 2 diabetes mellitus	0.00022	0.000714	CcSEcCtD
Atenolol—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000219	0.000712	CcSEcCtD
Atenolol—Headache—Bromocriptine—type 2 diabetes mellitus	0.000219	0.000712	CcSEcCtD
Atenolol—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000218	0.000711	CcSEcCtD
Atenolol—Nervousness—Ramipril—type 2 diabetes mellitus	0.000217	0.000707	CcSEcCtD
Atenolol—Dry mouth—Losartan—type 2 diabetes mellitus	0.000217	0.000707	CcSEcCtD
Atenolol—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000216	0.000702	CcSEcCtD
Atenolol—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000215	0.000701	CcSEcCtD
Atenolol—Confusional state—Losartan—type 2 diabetes mellitus	0.000215	0.000699	CcSEcCtD
Atenolol—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000214	0.000698	CcSEcCtD
Atenolol—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000214	0.000696	CcSEcCtD
Atenolol—Somnolence—Metformin—type 2 diabetes mellitus	0.000213	0.000694	CcSEcCtD
Atenolol—Oedema—Losartan—type 2 diabetes mellitus	0.000213	0.000693	CcSEcCtD
Atenolol—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000212	0.000688	CcSEcCtD
Atenolol—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000211	0.000687	CcSEcCtD
Atenolol—Shock—Losartan—type 2 diabetes mellitus	0.00021	0.000682	CcSEcCtD
Atenolol—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000209	0.000679	CcSEcCtD
Atenolol—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000209	0.000678	CcSEcCtD
Atenolol—Tachycardia—Losartan—type 2 diabetes mellitus	0.000208	0.000676	CcSEcCtD
Atenolol—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000208	0.000676	CcSEcCtD
Atenolol—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000207	0.000675	CcSEcCtD
Atenolol—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000207	0.000674	CcSEcCtD
Atenolol—Fatigue—Metformin—type 2 diabetes mellitus	0.000207	0.000673	CcSEcCtD
Atenolol—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000206	0.00067	CcSEcCtD
Atenolol—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000206	0.000669	CcSEcCtD
Atenolol—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000206	0.000669	CcSEcCtD
Atenolol—Constipation—Metformin—type 2 diabetes mellitus	0.000205	0.000667	CcSEcCtD
Atenolol—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000203	0.000661	CcSEcCtD
Atenolol—Anorexia—Losartan—type 2 diabetes mellitus	0.000203	0.000661	CcSEcCtD
Atenolol—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000203	0.00066	CcSEcCtD
Atenolol—Malaise—Ramipril—type 2 diabetes mellitus	0.000202	0.000657	CcSEcCtD
Atenolol—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000202	0.000657	CcSEcCtD
Atenolol—Rash—Glyburide—type 2 diabetes mellitus	0.000201	0.000655	CcSEcCtD
Atenolol—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000201	0.000655	CcSEcCtD
Atenolol—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000201	0.000654	CcSEcCtD
Atenolol—Vertigo—Ramipril—type 2 diabetes mellitus	0.000201	0.000654	CcSEcCtD
Atenolol—Syncope—Ramipril—type 2 diabetes mellitus	0.000201	0.000653	CcSEcCtD
Atenolol—Headache—Glyburide—type 2 diabetes mellitus	0.0002	0.000651	CcSEcCtD
Atenolol—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000199	0.000648	CcSEcCtD
Atenolol—Hypotension—Losartan—type 2 diabetes mellitus	0.000199	0.000648	CcSEcCtD
Atenolol—Palpitations—Ramipril—type 2 diabetes mellitus	0.000198	0.000643	CcSEcCtD
Atenolol—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000198	0.000643	CcSEcCtD
Atenolol—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000197	0.00064	CcSEcCtD
Atenolol—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000197	0.00064	CcSEcCtD
Atenolol—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000196	0.000638	CcSEcCtD
Atenolol—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000195	0.000636	CcSEcCtD
Atenolol—Cough—Ramipril—type 2 diabetes mellitus	0.000195	0.000635	CcSEcCtD
Atenolol—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000195	0.000635	CcSEcCtD
Atenolol—Pain—Irbesartan—type 2 diabetes mellitus	0.000194	0.00063	CcSEcCtD
Atenolol—Constipation—Irbesartan—type 2 diabetes mellitus	0.000194	0.00063	CcSEcCtD
Atenolol—Insomnia—Losartan—type 2 diabetes mellitus	0.000193	0.000627	CcSEcCtD
Atenolol—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000191	0.000622	CcSEcCtD
Atenolol—Chest pain—Ramipril—type 2 diabetes mellitus	0.000191	0.00062	CcSEcCtD
Atenolol—Dyspnoea—Losartan—type 2 diabetes mellitus	0.00019	0.000618	CcSEcCtD
Atenolol—Anxiety—Ramipril—type 2 diabetes mellitus	0.00019	0.000618	CcSEcCtD
Atenolol—Nausea—Glyburide—type 2 diabetes mellitus	0.00019	0.000617	CcSEcCtD
Atenolol—Dizziness—Gliclazide—type 2 diabetes mellitus	0.00019	0.000617	CcSEcCtD
Atenolol—Somnolence—Losartan—type 2 diabetes mellitus	0.000189	0.000616	CcSEcCtD
Atenolol—Asthenia—Valsartan—type 2 diabetes mellitus	0.000189	0.000615	CcSEcCtD
Atenolol—Discomfort—Ramipril—type 2 diabetes mellitus	0.000188	0.000612	CcSEcCtD
Atenolol—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000188	0.00061	CcSEcCtD
Atenolol—Asthenia—Orlistat—type 2 diabetes mellitus	0.000187	0.000607	CcSEcCtD
Atenolol—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000187	0.000607	CcSEcCtD
Atenolol—Pruritus—Valsartan—type 2 diabetes mellitus	0.000186	0.000606	CcSEcCtD
Atenolol—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000186	0.000606	CcSEcCtD
Atenolol—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000185	0.000602	CcSEcCtD
Atenolol—Confusional state—Ramipril—type 2 diabetes mellitus	0.000184	0.000599	CcSEcCtD
Atenolol—Pruritus—Orlistat—type 2 diabetes mellitus	0.000184	0.000599	CcSEcCtD
Atenolol—Fatigue—Losartan—type 2 diabetes mellitus	0.000184	0.000597	CcSEcCtD
Atenolol—Oedema—Ramipril—type 2 diabetes mellitus	0.000183	0.000594	CcSEcCtD
Atenolol—Constipation—Losartan—type 2 diabetes mellitus	0.000182	0.000593	CcSEcCtD
Atenolol—Pain—Losartan—type 2 diabetes mellitus	0.000182	0.000593	CcSEcCtD
Atenolol—Rash—Gliclazide—type 2 diabetes mellitus	0.000181	0.000588	CcSEcCtD
Atenolol—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000181	0.000588	CcSEcCtD
Atenolol—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.00018	0.000586	CcSEcCtD
Atenolol—Shock—Ramipril—type 2 diabetes mellitus	0.00018	0.000585	CcSEcCtD
Atenolol—Headache—Gliclazide—type 2 diabetes mellitus	0.00018	0.000584	CcSEcCtD
Atenolol—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000179	0.000582	CcSEcCtD
Atenolol—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000179	0.000582	CcSEcCtD
Atenolol—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000178	0.00058	CcSEcCtD
Atenolol—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000178	0.000579	CcSEcCtD
Atenolol—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000177	0.000574	CcSEcCtD
Atenolol—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000176	0.000571	CcSEcCtD
Atenolol—Dizziness—Valsartan—type 2 diabetes mellitus	0.000174	0.000567	CcSEcCtD
Atenolol—Anorexia—Ramipril—type 2 diabetes mellitus	0.000174	0.000566	CcSEcCtD
Atenolol—Propranolol—CYP1A2—type 2 diabetes mellitus	0.000173	0.0224	CrCbGaD
Atenolol—Dizziness—Orlistat—type 2 diabetes mellitus	0.000172	0.00056	CcSEcCtD
Atenolol—Asthenia—Metformin—type 2 diabetes mellitus	0.000172	0.00056	CcSEcCtD
Atenolol—Hypotension—Ramipril—type 2 diabetes mellitus	0.000171	0.000555	CcSEcCtD
Atenolol—Nausea—Gliclazide—type 2 diabetes mellitus	0.00017	0.000554	CcSEcCtD
Atenolol—Pruritus—Metformin—type 2 diabetes mellitus	0.00017	0.000552	CcSEcCtD
Atenolol—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000168	0.000548	CcSEcCtD
Atenolol—Rash—Valsartan—type 2 diabetes mellitus	0.000166	0.00054	CcSEcCtD
Atenolol—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000166	0.00054	CcSEcCtD
Atenolol—Insomnia—Ramipril—type 2 diabetes mellitus	0.000165	0.000537	CcSEcCtD
Atenolol—Headache—Valsartan—type 2 diabetes mellitus	0.000165	0.000537	CcSEcCtD
Atenolol—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000164	0.000534	CcSEcCtD
Atenolol—Rash—Orlistat—type 2 diabetes mellitus	0.000164	0.000534	CcSEcCtD
Atenolol—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000164	0.000534	CcSEcCtD
Atenolol—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000164	0.000533	CcSEcCtD
Atenolol—Headache—Orlistat—type 2 diabetes mellitus	0.000163	0.00053	CcSEcCtD
Atenolol—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000163	0.00053	CcSEcCtD
Atenolol—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000162	0.000528	CcSEcCtD
Atenolol—Somnolence—Ramipril—type 2 diabetes mellitus	0.000162	0.000528	CcSEcCtD
Atenolol—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000161	0.000523	CcSEcCtD
Atenolol—Pruritus—Irbesartan—type 2 diabetes mellitus	0.00016	0.000521	CcSEcCtD
Atenolol—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000159	0.000517	CcSEcCtD
Atenolol—Dizziness—Metformin—type 2 diabetes mellitus	0.000159	0.000516	CcSEcCtD
Atenolol—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000158	0.000513	CcSEcCtD
Atenolol—Fatigue—Ramipril—type 2 diabetes mellitus	0.000157	0.000512	CcSEcCtD
Atenolol—Nausea—Valsartan—type 2 diabetes mellitus	0.000156	0.000509	CcSEcCtD
Atenolol—Constipation—Ramipril—type 2 diabetes mellitus	0.000156	0.000508	CcSEcCtD
Atenolol—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000155	0.000504	CcSEcCtD
Atenolol—Nausea—Orlistat—type 2 diabetes mellitus	0.000155	0.000503	CcSEcCtD
Atenolol—Asthenia—Losartan—type 2 diabetes mellitus	0.000153	0.000497	CcSEcCtD
Atenolol—Rash—Metformin—type 2 diabetes mellitus	0.000151	0.000492	CcSEcCtD
Atenolol—Dermatitis—Metformin—type 2 diabetes mellitus	0.000151	0.000492	CcSEcCtD
Atenolol—Pruritus—Losartan—type 2 diabetes mellitus	0.000151	0.00049	CcSEcCtD
Atenolol—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000151	0.00049	CcSEcCtD
Atenolol—Headache—Metformin—type 2 diabetes mellitus	0.00015	0.000489	CcSEcCtD
Atenolol—Dizziness—Irbesartan—type 2 diabetes mellitus	0.00015	0.000487	CcSEcCtD
Atenolol—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000146	0.000474	CcSEcCtD
Atenolol—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000144	0.00047	CcSEcCtD
Atenolol—Rash—Irbesartan—type 2 diabetes mellitus	0.000143	0.000464	CcSEcCtD
Atenolol—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000143	0.000464	CcSEcCtD
Atenolol—Nausea—Metformin—type 2 diabetes mellitus	0.000142	0.000463	CcSEcCtD
Atenolol—Headache—Irbesartan—type 2 diabetes mellitus	0.000142	0.000461	CcSEcCtD
Atenolol—Dizziness—Losartan—type 2 diabetes mellitus	0.000141	0.000458	CcSEcCtD
Atenolol—Nausea—Irbesartan—type 2 diabetes mellitus	0.000134	0.000437	CcSEcCtD
Atenolol—Rash—Losartan—type 2 diabetes mellitus	0.000134	0.000437	CcSEcCtD
Atenolol—Dermatitis—Losartan—type 2 diabetes mellitus	0.000134	0.000437	CcSEcCtD
Atenolol—Headache—Losartan—type 2 diabetes mellitus	0.000133	0.000434	CcSEcCtD
Atenolol—Asthenia—Ramipril—type 2 diabetes mellitus	0.000131	0.000426	CcSEcCtD
Atenolol—Pruritus—Ramipril—type 2 diabetes mellitus	0.000129	0.00042	CcSEcCtD
Atenolol—Ibuprofen—PTGS2—type 2 diabetes mellitus	0.000127	0.0164	CrCbGaD
Atenolol—Nausea—Losartan—type 2 diabetes mellitus	0.000127	0.000412	CcSEcCtD
Atenolol—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000125	0.000407	CcSEcCtD
Atenolol—Dizziness—Ramipril—type 2 diabetes mellitus	0.000121	0.000393	CcSEcCtD
Atenolol—Rash—Ramipril—type 2 diabetes mellitus	0.000115	0.000375	CcSEcCtD
Atenolol—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000115	0.000374	CcSEcCtD
Atenolol—Headache—Ramipril—type 2 diabetes mellitus	0.000114	0.000372	CcSEcCtD
Atenolol—Propranolol—CYP3A4—type 2 diabetes mellitus	0.000114	0.0148	CrCbGaD
Atenolol—Ibuprofen—ALB—type 2 diabetes mellitus	0.000113	0.0147	CrCbGaD
Atenolol—Nausea—Ramipril—type 2 diabetes mellitus	0.000108	0.000353	CcSEcCtD
Atenolol—ADRB2—Signaling Pathways—GLP1R—type 2 diabetes mellitus	3.59e-05	0.000385	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—RBP4—type 2 diabetes mellitus	3.59e-05	0.000385	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—AVP—type 2 diabetes mellitus	3.58e-05	0.000385	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—MMP3—type 2 diabetes mellitus	3.58e-05	0.000385	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	3.56e-05	0.000383	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	3.56e-05	0.000382	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—SRD5A1—type 2 diabetes mellitus	3.54e-05	0.00038	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CCKAR—type 2 diabetes mellitus	3.53e-05	0.000379	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	3.52e-05	0.000378	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—EDN1—type 2 diabetes mellitus	3.48e-05	0.000374	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	3.43e-05	0.000368	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—EDN1—type 2 diabetes mellitus	3.41e-05	0.000366	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—HSD17B3—type 2 diabetes mellitus	3.38e-05	0.000363	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ACACA—type 2 diabetes mellitus	3.38e-05	0.000363	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—STAR—type 2 diabetes mellitus	3.38e-05	0.000363	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	3.38e-05	0.000362	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	3.36e-05	0.00036	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—C3—type 2 diabetes mellitus	3.35e-05	0.00036	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	3.33e-05	0.000357	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	3.31e-05	0.000355	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—C3—type 2 diabetes mellitus	3.28e-05	0.000352	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	3.27e-05	0.000351	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—IAPP—type 2 diabetes mellitus	3.25e-05	0.000349	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CBS—type 2 diabetes mellitus	3.24e-05	0.000348	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ABCC8—type 2 diabetes mellitus	3.24e-05	0.000348	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	3.24e-05	0.000347	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—INSR—type 2 diabetes mellitus	3.23e-05	0.000347	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	3.2e-05	0.000344	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	3.18e-05	0.000342	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—IAPP—type 2 diabetes mellitus	3.18e-05	0.000341	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	3.18e-05	0.000341	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	3.17e-05	0.00034	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—INSR—type 2 diabetes mellitus	3.16e-05	0.000339	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	3.16e-05	0.000339	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—SLC5A2—type 2 diabetes mellitus	3.12e-05	0.000335	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—COX2—type 2 diabetes mellitus	3.12e-05	0.000335	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—AGT—type 2 diabetes mellitus	3.12e-05	0.000334	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	3.11e-05	0.000334	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—TRPC6—type 2 diabetes mellitus	3.11e-05	0.000333	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	3.1e-05	0.000333	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	3.1e-05	0.000333	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—AGTR2—type 2 diabetes mellitus	3.09e-05	0.000331	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—NCOA6—type 2 diabetes mellitus	3.06e-05	0.000329	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—CCR5—type 2 diabetes mellitus	3.05e-05	0.000327	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—C3—type 2 diabetes mellitus	3.04e-05	0.000327	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	3.02e-05	0.000324	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	3.02e-05	0.000324	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—HSD11B1—type 2 diabetes mellitus	3.01e-05	0.000323	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—UCP3—type 2 diabetes mellitus	3.01e-05	0.000323	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—UCP2—type 2 diabetes mellitus	3.01e-05	0.000323	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—C3—type 2 diabetes mellitus	2.98e-05	0.00032	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—EDNRB—type 2 diabetes mellitus	2.96e-05	0.000317	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	2.94e-05	0.000316	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	2.94e-05	0.000315	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	2.94e-05	0.000315	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	2.91e-05	0.000312	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	2.9e-05	0.000311	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—AGT—type 2 diabetes mellitus	2.89e-05	0.00031	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	2.88e-05	0.000309	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	2.87e-05	0.000308	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	2.87e-05	0.000308	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	2.87e-05	0.000308	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	2.86e-05	0.000306	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	2.84e-05	0.000305	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CYBA—type 2 diabetes mellitus	2.84e-05	0.000305	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PCK1—type 2 diabetes mellitus	2.83e-05	0.000304	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—AGT—type 2 diabetes mellitus	2.83e-05	0.000304	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	2.79e-05	0.0003	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	2.79e-05	0.0003	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PLAT—type 2 diabetes mellitus	2.78e-05	0.000299	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—GHRL—type 2 diabetes mellitus	2.78e-05	0.000299	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	2.78e-05	0.000298	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CYBA—type 2 diabetes mellitus	2.78e-05	0.000298	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	2.78e-05	0.000298	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	2.77e-05	0.000297	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CALCA—type 2 diabetes mellitus	2.75e-05	0.000295	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	2.73e-05	0.000293	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PLAT—type 2 diabetes mellitus	2.72e-05	0.000292	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—GHRL—type 2 diabetes mellitus	2.72e-05	0.000292	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	2.72e-05	0.000292	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CALCA—type 2 diabetes mellitus	2.69e-05	0.000289	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	2.67e-05	0.000287	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—HK1—type 2 diabetes mellitus	2.65e-05	0.000285	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	2.61e-05	0.000281	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	2.6e-05	0.000278	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	2.59e-05	0.000278	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	2.59e-05	0.000278	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	2.58e-05	0.000276	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—HSD3B2—type 2 diabetes mellitus	2.56e-05	0.000275	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—GCKR—type 2 diabetes mellitus	2.56e-05	0.000275	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—KCNJ11—type 2 diabetes mellitus	2.56e-05	0.000275	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—LPA—type 2 diabetes mellitus	2.56e-05	0.000275	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—GCG—type 2 diabetes mellitus	2.54e-05	0.000273	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	2.54e-05	0.000273	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	2.53e-05	0.000272	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	2.52e-05	0.00027	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	2.5e-05	0.000269	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	2.5e-05	0.000268	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—GCG—type 2 diabetes mellitus	2.49e-05	0.000267	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	2.49e-05	0.000267	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ALDOB—type 2 diabetes mellitus	2.46e-05	0.000263	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	2.45e-05	0.000263	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	2.44e-05	0.000262	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	2.38e-05	0.000256	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.34e-05	0.000251	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	2.34e-05	0.000251	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	2.34e-05	0.000251	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	2.33e-05	0.00025	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	2.29e-05	0.000246	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	2.29e-05	0.000245	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	2.28e-05	0.000245	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	2.21e-05	0.000238	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.2e-05	0.000236	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—GNB3—type 2 diabetes mellitus	2.19e-05	0.000235	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	2.17e-05	0.000232	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—AVP—type 2 diabetes mellitus	2.16e-05	0.000232	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—MMP3—type 2 diabetes mellitus	2.16e-05	0.000232	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—IGF2—type 2 diabetes mellitus	2.15e-05	0.000231	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—GNB3—type 2 diabetes mellitus	2.15e-05	0.00023	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	2.14e-05	0.00023	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	2.13e-05	0.000229	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	2.12e-05	0.000228	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—AVP—type 2 diabetes mellitus	2.12e-05	0.000227	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—MMP3—type 2 diabetes mellitus	2.12e-05	0.000227	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—IGF2—type 2 diabetes mellitus	2.11e-05	0.000226	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	2.1e-05	0.000225	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—APOB—type 2 diabetes mellitus	2.09e-05	0.000224	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	2.09e-05	0.000224	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	2.09e-05	0.000224	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	2.08e-05	0.000224	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	2.08e-05	0.000223	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—EDN1—type 2 diabetes mellitus	2.06e-05	0.000221	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	2.05e-05	0.00022	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—APOB—type 2 diabetes mellitus	2.05e-05	0.00022	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	2.04e-05	0.000219	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	2.03e-05	0.000218	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	2.03e-05	0.000218	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	2.03e-05	0.000218	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	2.02e-05	0.000217	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—EDN1—type 2 diabetes mellitus	2.01e-05	0.000216	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—LPL—type 2 diabetes mellitus	2e-05	0.000214	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	1.99e-05	0.000213	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	1.96e-05	0.000211	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.95e-05	0.00021	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—LPL—type 2 diabetes mellitus	1.95e-05	0.00021	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	1.93e-05	0.000207	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.91e-05	0.000205	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.87e-05	0.000201	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.84e-05	0.000197	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.83e-05	0.000197	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	1.82e-05	0.000196	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	1.82e-05	0.000196	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	1.82e-05	0.000196	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.8e-05	0.000193	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—C3—type 2 diabetes mellitus	1.8e-05	0.000193	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	1.79e-05	0.000192	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	1.78e-05	0.00019	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—C3—type 2 diabetes mellitus	1.76e-05	0.000189	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.74e-05	0.000187	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	1.74e-05	0.000186	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.71e-05	0.000184	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.71e-05	0.000184	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—AGT—type 2 diabetes mellitus	1.71e-05	0.000183	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.68e-05	0.00018	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.68e-05	0.00018	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—LEP—type 2 diabetes mellitus	1.67e-05	0.00018	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—APOE—type 2 diabetes mellitus	1.67e-05	0.00018	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.67e-05	0.00018	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—AGT—type 2 diabetes mellitus	1.67e-05	0.000179	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	1.67e-05	0.000179	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.65e-05	0.000178	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	1.65e-05	0.000177	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	1.65e-05	0.000177	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.64e-05	0.000176	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—LEP—type 2 diabetes mellitus	1.64e-05	0.000176	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—APOE—type 2 diabetes mellitus	1.64e-05	0.000176	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.62e-05	0.000174	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	1.61e-05	0.000173	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	1.58e-05	0.00017	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	1.58e-05	0.00017	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.58e-05	0.000169	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.54e-05	0.000166	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.49e-05	0.00016	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.46e-05	0.000157	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—INS—type 2 diabetes mellitus	1.43e-05	0.000153	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.41e-05	0.000151	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—INS—type 2 diabetes mellitus	1.4e-05	0.00015	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.38e-05	0.000148	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.38e-05	0.000148	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.38e-05	0.000148	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.38e-05	0.000148	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.36e-05	0.000146	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	1.36e-05	0.000146	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	1.36e-05	0.000146	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.35e-05	0.000145	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.35e-05	0.000145	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.35e-05	0.000144	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	1.34e-05	0.000144	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.31e-05	0.000141	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	1.3e-05	0.00014	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.28e-05	0.000138	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	1.26e-05	0.000136	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.25e-05	0.000135	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.25e-05	0.000135	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	1.24e-05	0.000133	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.23e-05	0.000132	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.23e-05	0.000132	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	1.22e-05	0.00013	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	1.21e-05	0.00013	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.18e-05	0.000127	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	1.18e-05	0.000127	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.16e-05	0.000125	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.15e-05	0.000124	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	1.12e-05	0.00012	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	1.1e-05	0.000118	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.07e-05	0.000115	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.06e-05	0.000114	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	1.06e-05	0.000114	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.06e-05	0.000114	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.05e-05	0.000113	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	1.04e-05	0.000112	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.04e-05	0.000112	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	1.04e-05	0.000112	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.03e-05	0.000111	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	1.03e-05	0.00011	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.01e-05	0.000108	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.95e-06	0.000107	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.84e-06	0.000106	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.76e-06	0.000105	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.74e-06	0.000104	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.55e-06	0.000102	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—SRC—type 2 diabetes mellitus	9.28e-06	9.95e-05	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—SRC—type 2 diabetes mellitus	9.07e-06	9.74e-05	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	9.06e-06	9.73e-05	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.03e-06	9.69e-05	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—INS—type 2 diabetes mellitus	8.89e-06	9.54e-05	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.84e-06	9.48e-05	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.29e-06	8.9e-05	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	8.15e-06	8.75e-05	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.13e-06	8.72e-05	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.11e-06	8.7e-05	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.95e-06	8.53e-05	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	7.8e-06	8.37e-05	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	7.8e-06	8.37e-05	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	7.13e-06	7.65e-05	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—IL6—type 2 diabetes mellitus	6.25e-06	6.71e-05	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—IL6—type 2 diabetes mellitus	6.11e-06	6.56e-05	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.76e-06	6.19e-05	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.64e-06	6.05e-05	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	3.58e-06	3.85e-05	CbGpPWpGaD
